Literature DB >> 139479

Antibody to hepatitis A antigen in institutionalized mentally retarded patients.

W Szmuness, R H Purcell, J L Dienstag, C E Stevens.   

Abstract

Institutionalized patients with Down syndrome and matched controls with other causes of mental retardation were tested by immune adherence hemagglutination for the presence of antibody to hepatitis A antigen (anti-HA). Altogether 75.1% (175 of 233) exhibited presence of anti-HA, with no differences by sex or age. Patients reactive for hepatitis B surface antigen (HBsAg) or its antibody (anti-HBs) were reactive for anti-HA significantly more frequently than those with a negative reaction for these markers. In contrast to serologic markers of hepatitis type B, prevalence of anti-HA does not depend on the cause of mental retardation or on the age at primary infection. The rate of anti-HA positivity was found to be closely correlated with duration of institutionalization. The study confirmed that many closed institutions for the mentally retarded are hyperendemic for hepatitis type A and that formation of anti-HA is not greatly affected by either immune deficiency or immune immaturity.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 139479

Source DB:  PubMed          Journal:  JAMA        ISSN: 0098-7484            Impact factor:   56.272


  9 in total

1.  Prevalence of hepatitis A virus antibody among Navajo school children.

Authors:  R Williams
Journal:  Am J Public Health       Date:  1986-03       Impact factor: 9.308

2.  Serodiagnosis of viral hepatitis A by a modified competitive binding radioimmunoassay for immunoglobulin M anti-hepatitis A virus.

Authors:  D W Bradley; H A Fields; K A McCaustland; J E Maynard; R H Decker; R Whittington; L R Overby
Journal:  J Clin Microbiol       Date:  1979-01       Impact factor: 5.948

3.  Studies on the outbreak of hepatitis A in an institute for mentally retarded children.

Authors:  H Nara; K Suzuki; T Momma; M Ookawa; H Kawabe; Y Yoshida; F Tsuda; H Yoshizawa; M Mayumi
Journal:  Gastroenterol Jpn       Date:  1978

4.  Viral hepatitis A and B in hemodialysed patients.

Authors:  K Gmelin; B von Ehrlich; B Kommerell; E Ritz; J Bommer
Journal:  Klin Wochenschr       Date:  1980-04-01

5.  Detection of hepatitis A virus in the stools of healthy people from endemic areas.

Authors:  P De Filippis; M Divizia; A Mele; B Adamo; A Panà
Journal:  Eur J Epidemiol       Date:  1987-06       Impact factor: 8.082

6.  Exposure to school children as a risk factor in a community outbreak of hepatitis A in young adults: a case control study.

Authors:  R J Roberts; S R Palmer
Journal:  Epidemiol Infect       Date:  2005-11-29       Impact factor: 2.451

7.  Prevalence of hepatitis A antibody among disadvantaged gypsy children in northern Spain.

Authors:  G Cilla; E Perez-Trallero; J M Marimon; S Erdozain; C Gutierrez
Journal:  Epidemiol Infect       Date:  1995-08       Impact factor: 2.451

8.  Antibody to hepatitis A virus in healthy Nigerians.

Authors:  E A Ayoola
Journal:  J Natl Med Assoc       Date:  1982-05       Impact factor: 1.798

9.  Prevention of Hepatitis A Virus Infection in the United States: Recommendations of the Advisory Committee on Immunization Practices, 2020.

Authors:  Noele P Nelson; Mark K Weng; Megan G Hofmeister; Kelly L Moore; Mona Doshani; Saleem Kamili; Alaya Koneru; Penina Haber; Liesl Hagan; José R Romero; Sarah Schillie; Aaron M Harris
Journal:  MMWR Recomm Rep       Date:  2020-07-03
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.